These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 19109069)

  • 21. Preconditioning, postconditioning and their application to clinical cardiology.
    Kloner RA; Rezkalla SH
    Cardiovasc Res; 2006 May; 70(2):297-307. PubMed ID: 16516180
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacologic therapy that simulates conditioning for cardiac ischemic/reperfusion injury.
    Sivaraman V; Yellon DM
    J Cardiovasc Pharmacol Ther; 2014 Jan; 19(1):83-96. PubMed ID: 24038018
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Organ protection by conditioning].
    Bein B; Meybohm P
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2010 Apr; 45(4):254-61; quiz 262. PubMed ID: 20387183
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Postconditioning and protection from reperfusion injury: where do we stand? Position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology.
    Ovize M; Baxter GF; Di Lisa F; Ferdinandy P; Garcia-Dorado D; Hausenloy DJ; Heusch G; Vinten-Johansen J; Yellon DM; Schulz R;
    Cardiovasc Res; 2010 Aug; 87(3):406-23. PubMed ID: 20448097
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Mechanisms of myocardial cell protection from ischemia/reperfusion injury and potential clinical implications].
    Lamendola P; Di Monaco A; Barone L; Pisanello C; Lanza GA; Crea F
    G Ital Cardiol (Rome); 2009 Jan; 10(1):28-36. PubMed ID: 19292017
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical efforts to reduce myocardial infarct size--the next step.
    Braunwald E
    J Cardiovasc Pharmacol Ther; 2011; 16(3-4):349-53. PubMed ID: 21821538
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Letter regarding article by Argaud et al, "postconditioning inhibits mitochondrial permeability transition".
    Facundo HT; Kowaltowski AJ
    Circulation; 2005 Jun; 111(24):e442; author reply e442. PubMed ID: 15967857
    [No Abstract]   [Full Text] [Related]  

  • 28. Postconditioning: from experimental proof to clinical concept.
    Mewton N; Ivanès F; Cour M; Ovize M
    Dis Model Mech; 2010; 3(1-2):39-44. PubMed ID: 20075381
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical implications of apoptosis in ischemic myocardium.
    Scarabelli TM; Knight R; Stephanou A; Townsend P; Chen-Scarabelli C; Lawrence K; Gottlieb R; Latchman D; Narula J
    Curr Probl Cardiol; 2006 Mar; 31(3):181-264. PubMed ID: 16503249
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reperfusion injury in humans: a review of clinical trials on reperfusion injury inhibitory strategies.
    Dirksen MT; Laarman GJ; Simoons ML; Duncker DJ
    Cardiovasc Res; 2007 Jun; 74(3):343-55. PubMed ID: 17306241
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Persistent inhibition of mitochondrial permeability transition by preconditioning during the first hours of reperfusion.
    Argaud L; Loufouat J; Gateau-Roesch O; Gomez L; Robert D; Ovize M
    Shock; 2008 Nov; 30(5):552-6. PubMed ID: 18317409
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacological preconditioning with hyperbaric oxygen: can this therapy attenuate myocardial ischemic reperfusion injury and induce myocardial protection via nitric oxide?
    Yogaratnam JZ; Laden G; Guvendik L; Cowen M; Cale A; Griffin S
    J Surg Res; 2008 Sep; 149(1):155-64. PubMed ID: 17996900
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transient metabolic alkalosis during early reperfusion abolishes helium preconditioning against myocardial infarction: restoration of cardioprotection by cyclosporin A in rabbits.
    Pagel PS; Krolikowski JG
    Anesth Analg; 2009 Apr; 108(4):1076-82. PubMed ID: 19299764
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardioprotection and kallikrein-kinin system in acute myocardial ischaemia in mice.
    Messadi-Laribi E; Griol-Charhbili V; Gaies E; Vincent MP; Heudes D; Meneton P; Alhenc-Gelas F; Richer C
    Clin Exp Pharmacol Physiol; 2008 Apr; 35(4):489-93. PubMed ID: 18307747
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular aspects of ischaemic postconditioning.
    Kaur S; Jaggi AS; Singh N
    Fundam Clin Pharmacol; 2009 Oct; 23(5):521-36. PubMed ID: 19674116
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Unresolved issues in myocardial reperfusion injury.
    Buja LM; Weerasinghe P
    Cardiovasc Pathol; 2010; 19(1):29-35. PubMed ID: 19026571
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [New face of modified reperfusion: postconditioning].
    Smolka G; Gołba KS; Malinowski M; Deja M; Biernat J; Reszka B; Dalecka AM; Woś S
    Kardiol Pol; 2005 Oct; 63(4 Suppl 2):S450-6. PubMed ID: 20527400
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intracoronary acid infusion as an alternative to ischemic postconditioning in pigs.
    Rodríguez-Sinovas A; Cabestrero A; García del Blanco B; Inserte J; García A; García-Dorado D
    Basic Res Cardiol; 2009 Nov; 104(6):761-71. PubMed ID: 19444371
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Myocardial reperfusion injury: looking beyond primary PCI.
    Fröhlich GM; Meier P; White SK; Yellon DM; Hausenloy DJ
    Eur Heart J; 2013 Jun; 34(23):1714-22. PubMed ID: 23536610
    [TBL] [Abstract][Full Text] [Related]  

  • 40. What's new in salvage of the ischemic myocardium: estrogen postconditioning.
    Babiker FA; Joseph S; Juggi JS
    Med Princ Pract; 2011; 20(6):495-6. PubMed ID: 21986004
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.